eli lilly lawsuit tirzepatide update Novo Nordisk filed a against & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Lilly, Novo fight surge in

The pipeline for GLP-1 receptor agonists is strong, with ongoing research into dual and triple hormone receptor agonists to improve efficacy and reduce side effects

Kidney damage, typically resulting from dehydration caused by other side effects A potential risk of thyroid cancer animal studies have shown an increased risk for thyroid C-cell tumors, though that risk has not yet been confirmed in humans

This means injecting or taking frozen semaglutide could deliver little to no therapeutic benefit, wasting both your investment and treatment time during your weight loss journey

The FDA has approved multiple therapeutic classes for Crohn's disease management, with treatment selection based on disease severity, location, phenotype (inflammatory, stricturing, or penetrating), and prior treatment response